What is Avc used for?

Avc is indicated for Candidal vulvovaginitis, Vulvovaginitis.

Avc is developed by Pharmobedient.

What development phase is Avc in?

Avc is FDA-approved (marketed).

What is the generic name of Avc?

SULFANILAMIDE is the generic (nonproprietary) name of Avc.

Last reviewed 2026-04-20 · How we verify

Avc (SULFANILAMIDE)

Pharmobedient · FDA-approved approved Small molecule Quality 50/100

At a glance

Generic name	SULFANILAMIDE
Sponsor	Pharmobedient
Drug class	sulfanilamide
Target	Carbonic anhydrase 13
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved
First approval	1965

Approved indications

Candidal vulvovaginitis
Vulvovaginitis

Common side effects

No common side effects on file.

Key clinical trials

Screening and Treating Asymptomatic Bacteriuria Every Trimester and Preterm Birth (NA)
Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients (NA)
Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer (PHASE2)
Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria (PHASE4)
Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Avc CI brief — competitive landscape report
Avc updates RSS · CI watch RSS
Pharmobedient portfolio CI